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SUMMARY  
Background   
Thoracic epidural analgesia was regarded as ‘the gold standard’ for prevention of pain associated with 
thoracotomy. Meta-analysis and systematic reviews of epidural versus paravertebral blockade for 
thoracotomy conclude that although the analgesia was comparable, paravertebral blockade had a 
better short-term side effect profile.  However reduction in major complications including mortality 
has not been proven.  
Methods  
The UK pneumonectomy study was a prospective observational cohort study. All UK thoracic 
surgical centres were invited to take part in the study. Data presented here relates to the mode of 
analgesia and outcome. The primary endpoint was suffering a major complication. Data were 
analysed for 312 patients having pneumonectomy over one calendar year of 2005, from 24 UK 
thoracic surgical centres.  
 
Results  
The most common type of analgesia was epidural (61.1%) followed by paravertebral (31%). Epidural 
was associated with major complications (odds ratio 2.2, 95% confidence interval 1.1 - 3.8; P=0.02) 
when analysed alongside patient and perioperative factors, in stepwise logistic regression analysis. 
 
Conclusions 
This study has demonstrated an increased incidence of clinically important major post- 
pneumonectomy complications associated with thoracic epidural compared to paravertebral blockade 
technique. However, this study is unable to provide robust evidence to change clinical practice for a 
better clinical outcome. A large multicentre randomised controlled trial is now needed to compare the 
efficacy, complications and cost-effectiveness of epidural versus paravertebral blockade after major 
lung resection with the primary outcome for clinically important major morbidity 
 
Key words:  anaesthetic techniques ,epidural ; anaesthetic techniques ,paravertebral ; Surgery, 
thoracic; Postoperative Complications 
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Acute pain following thoracotomy can lead to cardio-respiratory complications as well as 
development of chronic pain. Thoracic epidural analgesia using local anaesthetic and opioid has been 
widely regarded as ‘the gold standard’ for prevention of pain associated with thoracotomy and for 
reduction of the associated complications. However, recent two meta-analysis and systematic reviews
1 
2
 comparing the analgesic efficacy and side effects of epidural versus paravertebral blockade for 
thoracotomy concluded that although the analgesia was comparable, paravertebral blockade had a 
better short-term side effect profile including a reduced incidence of urinary retention, hypotension, 
nausea and vomiting and pulmonary complications.  This suggests that paravertebral blockade may be 
superior to epidural, but these reviews did not evaluate the most important outcomes (major 
complications including mortality).  This prospective, national observational study of 
pneumonectomy outcome collected data on the types of analgesic techniques used and incidence of 
major complications. This will allow a more considered view of the optimal management of acute 
post-thoracotomy pain.  
METHODS 
Study Design     
This was a prospective, multi–centre observational cohort study. All UK thoracic surgical centres 
(n=35 in 2005) were invited to take part in the study. Twenty-eight of these centres across the UK 
participated in this multi-centred ethics committee and local R&D approved study.  A principal 
investigator at each site took responsibility of recruitment, data collection and follow up until hospital 
discharge. The more detailed study methodology was described in the paper ‘UK pneumonectomy 
outcome study (UKPOS): a prospective observational study of pneumonectomy outcome’.3 The 
present study analyses further data from the UKPOS database.  
 
Study Patients 
The inclusion criteria were all patients older than 18 years who underwent pneumonectomy for lung 
cancer in one calendar year (2005). Both planned pneumonectomy and on-table conversions from less 
radical pulmonary resection were included. The exclusion criteria were pneumonectomy for benign 
disease, pleuropneumonectomy, extended and completion pneumonectomy.  
 
Data Collection 
Electronic data collection sheets were distributed to all investigators.  Data collected included types of 
analgesic techniques as well as peri-operative patient, anaesthetic and surgical factors. In addition, 
data collected included fields to assess conformity between reporting centres. The data collection 
sheet is outlined in detail in Appendix 1. Once completed, the data sheet was transmitted to the data 
centre (Birmingham Heartlands Hospital) where it was checked for errors.  
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Outcome Measures 
The primary outcome was the development of a major complication, which was predefined a potential 
life-threatening complication requiring interventions or leading to death. Major complications 
included the following: significant arrhythmias requiring anti-arrhythmias, noteworthy haemodynamic 
instability requiring inotropes, severe respiratory complications requiring mechanical support (CPAP, 
non-invasive or invasive ventilation), unexpected ICU admissions, further surgery or 30 day 
mortality.  
 
Statistical Analysis 
An independent senior statistician analysed the data using SPSS Statistics version 17.0 software 
(SPSS Inc, Chicago, USA). Data were tested for normality using Shapiro-Wilk’s W test. The 
quantitative variables were analysed using the unpaired t test and Mann Whitney U test for normally 
and non-normally distributed data respectively. The categorical data were analysed by the Chi-
squared test, Fisher’s exact test and Mann Whitney U test as appropriate.  Associations between 
analgesia techniques and major complications were tested with stepwise logistic regression analysis; 
taking into account commonly reported risk factors: age, ASA grades, pre-operative lung functions, 
airway pressures during one lung ventilation, types of analgesia and fluid management, for major 
complications following pneumonectomy. A P value of less than 0.05 was considered statistically 
significant.  Data were presented as median (inter-quartile range), mean (SD) or as a number (%).   
 
RESULTS 
The data centre received information for 312 patients from 24 centres distributed across the UK.  
Another four centres with site specific approval did not perform any pneumonectomies during the 
study period. Ninety two percent of the thoracic surgical centres were teaching hospitals.  
 
Types of analgesia 
Data on types of analgesic techniques were available for 98.1% of cases (n=306). The most common 
type of analgesia was epidural (n=187, 61.1%) followed by paravertebral blockade (n=95, 31%).  The 
other 7.8% of patients had alternative types of analgesia, which included patient controlled analgesia 
(4.9%), intrathecal morphine (1.6%) and intravenous morphine (1.3%).  78.9% of patients who 
received paravertebral blockade also received systemic opioids via patient controlled analgesia. 5.3% 
of cases had paravertebral blockade combined with intrathecal morphine. The systemic analgesic 
adjuncts used were as followed in percentage of all patients: paracetamol 60.3%, non-steroidal anti-
inflammatory drugs 21.5%, tramadol 18%, nefopam 8%, codeine based preparations 18%, pethidine 
0.3%. There were no differences between the epidural (n=146, 78% patients who received an 
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epidural) and paravertebral (n=72, 76% patients who received a paravertebral blcok) groups in use of 
non-steroidal anti-inflammatory drugs or paracetamol. 
 
In the epidural group (n=187), a combination of epidural local anaesthetic and opioids was used in 
62.6% of epidurals (n=117) whilst a combination of epidural local anaesthetic and systemic opioids 
was used in 3.2% of epidurals (n=6) and epidural opioids alone was used in 1.1% (n=2). However, for 
33.2% (n=62) of epidurals the drug mixture used was not specified. For epidurals the most common 
local anaesthetic used was bupivacaine (concentration range 0.08 – 0.15%) and the most common 
opioid used was fentanyl (concentration range 2 – 10mcgml-1). In the paravertebral group (n=95), 
local anaesthetic alone was used in 46.3% of patients (n=43, 40% with 0.1 – 0.5% bupivacaine or 
6.3% with lidocaine) whilst a mixture of bupivacaine with fentanyl was used in 6.3% of patients. 
However, for 47.4% (n=45) of patients the drug mixture used was not specified. The analgesic 
technique varied according to centre, 68.5% (n=128) of epidural analgesia was performed in the 12 
centres where more than ten pneumonectomies (cases) per year were carried out. (p=0.002).  
 
Patient characteristics 
As shown in Table 1, there were no differences in patient characteristics, ASA grade, co-morbidities 
or side of surgery between two groups. However, the patients that received paravertebral blockade 
weighed more than those that received epidural analgesia (p=0.04) although this difference did not 
reach statistical significance in terms of Body Mass Index (BMI) between two groups.  
 
Pulmonary Function 
There were no significant differences in pre-operative or post-operative predicted pulmonary function 
between epidural and paravertebral groups as shown in Table 2. 
 
Peri-operative management 
Table 3 shows most risk factors known to be associated with poor outcomes after lung surgery. The 
patients who had epidural analgesia had a significantly lower fluid balance per kilogram 24 hours 
post-operatively (p=0.003). There was a trend towards significant prolonged duration of surgery 
(p=0.07) and duration of one-lung ventilation (p=0.06) in the epidural analgesia group compared with 
paravertebral analgesia group. There was no significant difference between the two groups in location 
of post-operative care in a critical care area (ICU or HDU) or general ward. However, for critical care 
users, significant number of patients in the epidural group were transferred to Intensive Care Unit 
(level 3 care, 30/134, 18.3%) compared with 8.4% (7/76, P=0.003) in the paravertebral blockade 
group.  
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Mortality and Major Complications 
The in-hospital mortality was 4.8% (n=15) and the 30-day mortality 5.4% (n=17). Respiratory causes 
accounted for 58.8% of 30 day mortality (pneumonia, n=5; acute respiratory distress syndrome, n=3; 
pulmonary aspiration, n=1; and respiratory failure, n=1).  Major haemorrhage accounted for 23.5% 
(n=4) and myocardial infarction for 17.6% (n=3).  A total of 133 major complications occurred in 99 of 
312 patients (31.7%). 
 
In stepwise logistic regression analysis the use of epidural anaesthesia was found to be an independent 
risk factor for major complications (odds ratio (OR) 2.2, 95% confidence interval (CI) 1.1 to 3.8; 
p=0.02). The other factors that were associated with complications in stepwise logistic regression 
analysis were age (OR 1.07, CI 1.04 to 1.11; p=0.001), ASA (OR 1.7, CI 1.0 to 2.9; p=0.05) and DLCO  
(OR 0.78 (0.64 to 0.95; p=0.02). The incidence of major complications in the epidural and paravertebral 
groups is listed in Table 4.  
 
DISCUSSION 
This study has shown that in the UK epidural blockade is the most popular method of analgesia for 
pneumonectomy (61.1%), followed by paravertebral blockade (31%). The rate of major complications 
associated with pneumonectomy was high at 31.7%, and this figure is similar to complication rates 
reported in the literature more than 10 years ago.
4-7 
 
 
The main strength of this study is that it is the largest prospective investigation into analgesia 
techniques and morbidity following elective pneumonectomy for cancer, and therefore the findings are 
representative of current UK practice. Moreover, the study was performed over one calendar year to 
reduce variability over time. The Society of Cardiothoracic Surgeons of Great Britain returns for 2005 
– 2006 recorded 416 pneumonectomies for primary lung cancer, but this number would include 
completion or extended pneumonectomies not relevant to our study.
8
 Our data capture of 312 
pneumonectomies represent at least 75% of the case load performed in the UK in a calendar year. To 
our knowledge this is the largest prospective cohort study identifying that epidural blockade was 
associated with major complications in multiple logistic regression analysis.  
 
Prevalence of analgesia techniques 
It is encouraging to see that either epidural or paravertebral blockade was used in most cases of 
pneumonectomy (92.1%) as these techniques have been shown to provide superior analgesia and less 
post-operative morbidity when compared with intravenous opioid techniques.
7
 Thoracic epidural 
analgesia using local anaesthetic and opioid has been regarded world-wide as ‘the gold standard’ for 
managing acute post-thoracotomy pain, and our study has confirmed that this is the most common 
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analgesic technique in UK practice: over two-third patients were provided with thoracic epidural and 
94% of these patients received a combination of local anaesthetic and opioid via epidural route. By 
contrast, 86% of paravertebral blocks used local anaesthetic alone but were combined with systemic 
opioid (PCA in 78.9% of cases) or spinal route (intrathecal morphine in 5.3% of cases).  
 
Analgesia technique and pneumonectomy outcome 
The most interesting finding of this study was the increased incidence of major complications in the 
epidural group.  The data have shown that the increased incidence of major complications for the 
epidural group is spread across complications, with increases in hypotension requiring inotropes, 
arrhythmias requiring antiarrhythmics, respiratory complications requiring ventilatory support and the 
need for further surgery in the epidural group contributing to the overall significant difference 
compared with paravertebral blockade.  Some of these complications are known to be associated with 
epidural analgesia (such as hypotension) but others are not. The reason that paravertebral blockade 
may be associated with less hypotension and a reduction in pulmonary complications is because it is a 
unilateral technique and so respiratory and sympathetic function is preserved on the contra-lateral 
side.
9
  
 
There were few significant differences between patient characteristics or peri-operative anaesthetic or 
surgical factors between groups. A surprising finding was that the epidural group received 
significantly less fluid at 24 hr than the paravertebral group (mean 14.8 vs 20.4 ml kg
-1
, P=0.003) 
though neither value is excessive. Although one might expect hypotension following bilateral 
sympathetic blockade to be managed by additional fluid it was possibly managed in this study by the 
increased use of inotropes in the epidural group (5.3% vs 1.1%). The duration of surgery, duration of 
one-lung ventilation and blood loss were not significantly different between the two groups indicating 
that difficulty of surgery cannot account for the higher complication rate in the epidural group. There 
was an association between type of analgesia and thoracic centre; the centres that performed more 
than ten pneumonectomies in the year were more likely to use epidural analgesia. There is therefore a 
possibility that the thoracic centre has confounded this result. One hypothesis is that the centres doing 
more cases are also operating on ‘sicker patients’. However there were no differences between ASA 
grades, co-morbidities or lung function tests between epidural and paravertebral groups so this is 
unlikely to be the case. It is also unlikely to be related to the type of surgery as cases of 
pleuropneumonectomy, extended or completion pneumonectomy and pneumonectomy for benign 
disease were excluded from the study.  Another explanation is that this association is due to 
differences in post operative care between centres. However this seems unlikely as 21/30 ICU 
admissions in the epidural group were from one thoracic centre. This probably is a consequence of 
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differences in training and analgesia protocols between study centres but these data were not 
collected. 
Analgesia technique and locations of postoperative care 
It is expected that patients following pneumonectomy to be nursed in a critical care facility (ICU or 
HDU) for postoperative invasive monitoring regardless of type of analgesic technique provided. 
However, there was approximate one in ten patients (11.3% -epidural vs 12.6% - PVB) directly sent 
to the general wards. Regarding critical care, we found a significant higher requirement for 
postoperative ICU care in epidural group compared with PVB group, which has cost implications in 
NHS. An Intensive Care Unit provides level 3 care (ref), at present, ICU costs £1,780 per bed per day 
and HDU costs £ 633 per bed per day (ref, please look at internet). In terms of post-operative 
management of different types of analgesic technique, use of PVB has potential benefits as post-
operative management of epidural infusion requires critical care unit or a specialized ward whilst 
PVB can be managed on an ordinary ward.
4 5
   
 
Comparison with other studies 
Davies et al recently published a meta-analysis comparing the analgesic efficacy and common side 
effects of epidural and paravertebral blockade.
1
 They studied 520 adults from 10 randomised 
controlled trials undergoing thoracic surgery from 1989 to 2005. They found an increased incidence in 
common side effects associated with epidural analgesia when compared with paravertebral blockade. 
Paravertebral blockade was associated with less urinary retention, less hypotension, less nausea and 
vomiting and a reduction in pulmonary complications as well as higher successful rates. The small 
numbers in each study and the fact that most of the epidural infusions did not include opioids are both 
salient limitations to this meta-analysis.
1 
In a more recent systematic review, after reviewing the 
randomised controlled trials evaluating regional techniques for post-thoracotomy analgesia (ref 8) 
between 1966 to 2004, Joshi et al confirmed that paravertebral blockade provided a significantly 
lower incidence of post-operative hypotension or pulmonary complications than thoracic epidural. 
These two reviews suggest that paravertebral blockade may be superior to epidural, but these reviews 
did not evaluate the most important outcomes (serious complications including mortality).  To our 
knowledge, this cohort study is the largest worldwide prospective multi–centre investigation into 
analgesia techniques and major morbidity following elective pneumonectomy (UKPOS 2005), and the 
only study to quantify the comparisons of association of thoracic epidural or paravertebral block with 
clinically important major complications.    
 
Limitations 
9 
 
However, this study has some limitations. It is not a randomised controlled trial therefore has the 
inherent weakness of an observational study. As an observational study, the analgesia techniques were 
not standardised and certain variables were not measured adequately, for example, the efficacy of pain 
relief, the drug mixtures used or morphine consumption of each technique. Davies et al
1
 in their 
systemic review concluded that technique failure rates were higher in the epidural group which may 
have partly accounted for the increase in side effects. The data of epidural failure rate was not 
available in our study, and it is possible the failure of epidurals led to inadequate analgesia which 
resulted in higher major complications in epidural group. Another potential confounding factor is the 
association of analgesia technique with thoracic surgical centre; epidural being more common in 
centres that perform more than 10 pneumonectomies per year. It is difficult to determine how much 
centre variation in practice may have influenced our result of epidural being associated with major 
complications. We are not able to say whether certain thoracic surgical centres have lower morbidity 
because they use paravertebral analgesia or whether it is due to unidentified confounding factors. 
Finally with the overall reduction in the number of pneumonectomies being performed as a 
percentage of lung resections over the last decade, the extrapolation of these results to patients with 
lesser resections becomes even more relevant.
6
  
 
Conclusions 
This study has demonstrated an increased incidence of clinically important major post- 
pneumonectomy complications associated with thoracic epidural compared to paravertebral blockade 
technique. However, this study is unable to provide robust evidence to change clinical practice for a 
better clinical outcome. A large multicentre randomised controlled trial is now needed to compare the 
efficacy, complications and cost-effectiveness of epidural versus paravertebral blockade after major 
lung resection with the primary outcome for clinically important major morbidity. 
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Table 1: Patient characteristics for epidural and paravertebral groups, (medians [ranges] or 
number of patients (%) unless otherwise specified 
Characteristic      Epidural  
(n=187) 
Paravertebral 
(n=95) 
P value 
Age (years)                            
Weight (kg)                           
Body mass index (kgm
-2
)       
Male 
ASA ≥3 
Hypertension 
Asthma/ COPD 
Ischaemic heart disease 
Diabetes 
Myocardial infarction 
Gastro-oesophageal reflux 
Renal impairment 
Heart failure 
Neo-adjuvant therapy 
Right sided procedures 
62          [30-86] 
70.5       [40-115] 
25          [16.6-41] 
119 (64.3%)     
76 (41.4%)     
65 (34.9%)    
42 (22.6%)     
24 (12.9%)     
13 (7%)         
12 (6.5%)       
12 (6.5%)       
4 (4.4%)       
1 (0.5%)      
17 (9.4%)      
66 (35.7%)   
65         [39-83] 
76         [47-116] 
25.5      [18.8-37] 
66 (73.3%)     
41 (45.6%)     
26 (28.9%)     
20 (22.2%)     
18 (20%)        
8 (8.9%)       
8 (8.9%)       
6 (6.7%)       
4 (2.2%)      
0 (0%)        
12 (13.3%)   
30 (33.3%)    
0.08 
0.04 
0.06 
0.17 
0.52 
0.34 
1.00 
0.15 
0.63 
0.47 
1.00 
0.45 
1.00 
0.40 
0.79 
COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiology 
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Table 2: Pre-operative pulmonary function for epidural and paravertebral groups (medians 
and [ranges] unless otherwise specified) 
Pulmonary function  Numbers Epidural Paravertebral P value 
FEV1/FVC 
FEV1 
FEV1 % 
ppo FEV1% 
DLCO 
DLCO % 
ppo DLCO % 
Pre-op saturations < 95% 
174, 89 
186, 89 
181, 87 
183, 89 
102, 40 
106, 43 
105, 43 
21 
69      [41.3-90.5] 
2.14   [0.82-4.1] 
78.9   [35.8-130.8] 
40      [19-69.3] 
5.6     [0.8-12.2] 
69      [29-136] 
34.6   [15.3-71.6] 
16      (9.8%) 
67.7     [37-100] 
2.25     [0.49-3.66] 
77.7      [17.4-125.6] 
39.1     [8.1-66.6] 
6.3       [3.1-11.8] 
72        [39-112] 
37        [20.5-53.1] 
5           (7.8%) 
0.33 
0.84 
0.47 
0.55 
0.30 
0.17 
0.25 
0.80 
FEV1, forced expiratory volume (l) in one second; FVC, forced vital capacity (l); FEV1% percentage of measured FEV1 to 
predicted normal; ppo, predicted post-operative; DLCO, diffusion capacity for carbon monoxide needs unit . 
 
Table 3: Peri-operative management for epidural and paravertebral groups (median and 
[range] unless otherwise specified) 
Peri-operative management Number  Epidural Paravertebral P value 
Blood loss during surgery (ml) 
Fluid balance at 24hrs (ml kg
-1
) 
Duration of surgery (min) 
Duration of OLV (min) 
Plateau inspiratory pressure >25 cm H2O (vs  25) 
Pressure vs volume controlled ventilation) 
Converted procedure (vs planned) 
Stump closure with staples (vs sutures) 
Postop location  ICU and HDU vs ward  
Post-op location – ICU vs HDU 
187, 95 
174, 84 
182, 90 
172, 89 
155, 67 
178, 89 
186, 90 
185, 67 
185,95 
164,83 
390 [200-700] 
14.8 [-42.3-87.6] 
150  [67-460] 
120  40-450  
33 (21.2%)   
85 (47.5%)   
58 (31.2%)   
163 (88.1%)  
164 (88.7%) 
30 (18.3%)  
350 [200-700] 
20.4   [-6-62.5] 
140.5 [75-330] 
115 45-270  
15 (22.4%)   
37 (41.6%)   
32 (35.6%)   
57 (85.1%) 
83 (87.4%) 
7 (8.4%)  
0.46 
0.003 
0.07 
0.06 
0.49 
0.37 
0.50 
0.53 
0.43 
0.003 
Number indicates the number of patients in each group (epidural, paravertebral) with complete 
dataset in that field 
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Table 4: Incidence of major complications between epidural and paravertebral groups and 
length of hospital stay 
Complications Epidural         
number patients (%) 
N=187 
Paravertebral      
number patients (%) 
N=95 
P value 
Major complication 
Arrhythmia 
Atrial fibrillation 
Hypotension needing inotropes 
Respiratory  
Unplanned ICU admissions 
Further surgery 
30 day mortality 
Length of hospital stay (days) 
66 (35.3)   
39 (20.9)  
34 (18.2) 
10 (5.3)   
14 (7.5) 
17 (9.1)   
10 (5.3)  
12 (6.4)  
8 [1-63] 
22 (23.1)  
17 (18.9)  
16 (17.8)  
1 (1.1) 
4 (4.4)  
4 (4.4)  
2 (2.2 ) 
4 (4.2)  
 8 [4-27] 
0.049 
0.75 
1.00  
0.11 
0.44 
0.23 
0.35 
0.80 
0.74 
Length of hospital stay; median [range] 
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APPENDIX 1 
 
Essential fields from data collection sheet 
Centre code    
Patient number   
Date of surgery 
Age of patient    
Gender     
Height (m) 
Weight (kg)    
BMI (kg/m
2
)    
Exercise capacity (distance on flat in metres) 
Alcohol intake (units per week) 
Ever smoked (yes/no) 
Pack year history (average number of cigarettes smoked per day divided by 20, multiplied by total number of 
years smoked) 
Time since stopped smoking (weeks) 
ASA physical status 
Co-morbidities (Include all cardiac, respiratory, renal and vascular history and any other potentially relevant 
past history) 
Pre-operative medication (Include steroids, NSAIDs, antifungals, leukotriene receptor antagonists, beta-2 
agonists, and all ‘cardiac drugs’) 
Lung cancer stage (pre-operative) 
Cancer cell type 
Adjuvant chemo- or radiotherapy (what drugs/ radiation/ dose/ regime /and when) 
FEV
1
 (actual value in litres), FEV
1
 % (as percent of predicted value) 
FEV
1
 / FVC (as percentage)  
DLCO (actual value), DLCO % (as percentage of predicted normal) 
KCO (actual value), KCO % (as percent of predicted normal) 
Arterial line inserted 
Central venous pressure line inserted  
Mini-trach or tracheostomy inserted (if so when inserted and time in-situ) 
Pressure or volume controlled ventilation (during surgery) 
Fluids given during surgery (list fluid given in millimetres and type of fluid given) 
Drugs given during surgery and during post-operative period (all non anaesthetic drugs, e.g. diuretics, inotropes, 
antibiotics not normally taken by patient, received during the first 48 hours post-operatively and for entire length 
of stay on ICU/HDU) 
Blood loss during surgery 
Planned or converted 
Duration of intermittent positive pressure ventilation (in minutes) 
Duration of one-lung ventilation (in minutes from initiation to completion of surgery) 
Duration of surgery (in minutes from skin incision to final suture) 
Initial post-operative location 
Unplanned ICU admission 
ICU length of stay (in days) 
Types of post-operative pain relief (state which drugs, regime and route) 
Fluids given after surgery in first 24 hours 
Output (fluid output during surgery up to 24 hours- include urine output, chest drain output and any other 
losses) 
Fluid balance (fluid balance at 24 hours post-operatively, give figure in millimetres and whether positive or 
negative) 
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Post-operative complications (list organ systems and exact complications for respiratory, cardiovascular, renal, 
hepatic systems, sepsis, multi-organ failure) 
Post-pneumonectomy pulmonary oedema (diagnosed as hypoxia PF ratio < 40, bilateral infiltrates on chest x-
ray, PAP < 18mmHg when measured, cardiac index > 3 when PiCCO or oesophageal Doppler used, PEEP 
requirement ≥ 7.5mmHg) 
Survived to discharge 
Length of stay in hospital (to death or discharge in days) 
Cause of death (from death certificate or post mortem) 
 
APPENDIX 2 
The UKPOS Centre Co-ordinators: Clinical centres: Aberdeen Royal Infirmary, Aberdeen – L. 
Strachan; Barts and the London, London – J. Nelson, V. Brown; Birmingham Heartlands Hospital, 
Birmingham – F.Gao; Blackpool Victoria Hospital, Blackpool – A. Knowles; Cardiothoracic 
Centre, Liverpool – J. Kendall; Edinburgh Royal Infirmary, Edinburgh – G. Bowler; Freeman 
Hospital, Newcastle – L. Pardeshi; Glasgow Royal Infirmary, Glasgow – M. Stockwell; Glasgow 
Western Infirmary, Glasgow – A. Macfie; Guy’s and St Thomas’ Hospital, London – A. Pearce; 
HairmyresHospital, Haimyres – B. McCulloch; Harefield Hospital, London -  J. Mitchell; James 
Cook University Hospital, South Cleveland –M. Foley; Leeds General Infirmary, Leeds -  R. Mills; 
Manchester Royal Infirmary, Manchester – M. Forrest; Morriston Hospital, Swansea – M. Gilbert; 
New Cross Hospital, Wolverhampton – R. Giri; Norfolk and Norwich University Hospital, Norwich 
– N. Woodall; Northern General Hospital, Sheffield – D. Woodward; Nottingham City Hospital, 
Nottingham – J. Latter; Royal Devon and Exeter Hospital, Exeter – C. Berry; University Hospital of 
Wales, Cardiff – T. Dhallu; Wessex Cardiothoracic Centre, Southampton – L. Nel; Wythenshaw 
Hospital, Manchester – G. Lee. 
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